Halliburton's Q1 2026 Earnings Call Reinforces North America Weakness, Leaving Self-Help Thesis Untested

What happened

Halliburton's Q1 2026 earnings call confirmed the anticipated softness in North America, with management highlighting ongoing pricing pressure and reduced stimulation activity in U.S. land, consistent with prior disclosures of high-single-digit revenue declines. Cost-saving initiatives are on track to deliver the $100M per quarter savings, but these efforts face headwinds from persistently low frac spreads, which remain at 166, down 19% year-over-year and below the stabilization threshold of 175. International revenue showed modest growth, yet it failed to accelerate meaningfully, with the call not announcing significant new offshore awards to bolster the completion-tools order book. Capital discipline was reiterated, with capex guidance held near ~$1.1B, but the lack of a clear international catalyst leaves the stock reliant on North America margin defense through stacking and efficiency gains. Overall, the earnings call provided no surprises, aligning with the DeepValue report's WAIT rating by underscoring the unproven nature of the self-help and international offset narratives.

Implication

The earnings call solidifies the bearish risks outlined in the DeepValue report, with North America pricing concessions and low frac spreads persisting, threatening to overwhelm cost savings if utilization does not improve. International revenue, while stable, lacks the acceleration needed to offset domestic weakness, making the 'international pillar' narrative less convincing without new multi-year awards. Cost discipline and capex control offer some support, but the stock's valuation already discounts successful execution, leaving little room for error. Insider selling patterns and ongoing risks like the IRS dispute add to the uncertainty, suggesting that capital returns could be pressured if free cash flow falters. Therefore, the implication is clear: wait for tangible improvements in North America indicators or international contract wins before considering an entry, as the current setup offers limited upside against heightened downside exposure.

Thesis delta

The Q1 2026 earnings call does not alter the investment thesis; instead, it reinforces the need for patience by confirming that North America revenue declines and pricing pressure are real, not theoretical. International growth remains tepid, failing to provide the de-risking cushion that the market narrative assumes, which keeps the thesis centered on cost savings and capital discipline as fragile defenses. No shift is warranted—the WAIT rating stands, with the next 2-3 quarters still critical for validating margin protection and international conversion against a backdrop of unimproved utilization metrics.